This study found that chronic hyperglycemia can cause coagulation dysfunction at admission in AIS patients, manifested by elevated fibrinogen (Fbg) levels and shortened prothrombin time (PT), suggesting that fibrinolysis resistance and hypercoagulability may be key pathological mechanisms for poor prognosis in AIS patients with high blood sugar. This evidence concerns the gene F2 and androgen insensitivity syndrome.